跳轉至內容
Merck

跳轉至

04-1663

Goat Anti-Mouse IgG Antibody, clone RMG07

登入 檢視組織與合約價格。

選擇尺寸

變更視圖
包裝尺寸庫存單位供貨能力價格

關於此項目

UNSPSC Code:
12352203
NACRES:
NA.41
eCl@ss:
32160702
Clone:
RMG07, monoclonal
Species reactivity:
mouse
Application:
ELISA
Citations:
-
暫時無法取得訂價和供貨情況
技術服務
需要援助?我們經驗豐富的科學家團隊隨時樂意為您提供支援。
讓我們為您提供幫助


antibody form

purified antibody

Quality Level

clone

RMG07, monoclonal

purified by

using protein G

species reactivity

mouse

concentration

(Please refer to lot specific datasheet.)

technique(s)

ELISA: suitable

isotype

IgG

General description

Mouse IgG

Biochem/physiol Actions

This antibody reacts to Mouse IgG, including IgG1, IgG2a, IgG2b, and IgG3. No cross reactivity with IgM, IgA, IgE, human IgG, rat IgG, or rabbit IgG.

Physical form

Goat monoclonal in PBS with 1% BSA and 0.09% sodium azide.

Preparation Note

Stable for 1 year at 2-8°C from date of receipt.Note: Variability in freezer temperatures below -20°C may cause glycerol containing solutions to become frozen during storage.

Analysis Note

ELISA Analysis: The specificity and reactivity of a representative lot was confirmed by ELISA analyses.

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.


存儲類別/等級

12 - Non Combustible Liquids

wgk

WGK 2

flash_point_f

Not applicable

flash_point_c

Not applicable



分析證明 (COA)

輸入產品批次/批號來搜索 分析證明 (COA)。在產品’s標籤上找到批次和批號,寫有 ‘Lot’或‘Batch’.。

已經擁有該產品?

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫


相關內容

A major focus of breast cancer research is to understand the mechanisms responsible for disease progression and drug resistance. Toward that end, it has been found that approximately two thirds of all human breast carcinomas overexpress the Estrogen Receptor α (ERα) protein and it remains the primary pharmacological target for endocrine therapy1,2. The normal cellular function of ERα is as a transcription factor that mediates a wide variety of physiological processes, many of which are dependent upon phosphorylation of the receptor at specific amino acid residues3,4. Indeed, ERα is known to be phosphorylated at a multitude of different sites, yet how these all correlate to disease remains unclear5. Here, we interrogated multiple sites of ERα for phosphorylation status by screening an extensive panel of different breast cancer patient samples and other non-breast cancer tissue microarray (TMA) slide samples to determine their relevance to disease.